RNK08954
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for RNK08954, covering 2025-10-30 to 2026-02-27. Get the full timeline:
Most recent: Clinical Trial Update: IN10018 in Combination With RNK08954 for the Treatment of KRASG12D Mutation-Positive Locally Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]